BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24067332)

  • 1. Vecuronium pharmacokinetics in patients with major burns.
    Vega-Villa KR; Kaneda K; Yamashita S; Woo S; Han TH
    Br J Anaesth; 2014 Feb; 112(2):304-10. PubMed ID: 24067332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blockade with vecuronium in paediatric patients with burn injury.
    Mills AK; Martyn JA
    Br J Clin Pharmacol; 1989 Aug; 28(2):155-9. PubMed ID: 2570602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
    Caldwell JE; Szenohradszky J; Segredo V; Wright PM; McLoughlin C; Sharma ML; Gruenke LD; Fisher DM; Miller RD
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1216-22. PubMed ID: 7932174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
    Yajima C; Sugai N; Hanaoka K; Numata K; Yamamoto K; Kushida Y; Murakami S; Yamamura H
    Masui; 1990 Jul; 39(7):882-9. PubMed ID: 1976829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance to vecuronium in burnt patients. Influence of the burnt surface on the effectiveness of the dose 95].
    Badetti C; Pascal L; Bernini V; Manelli JC
    Ann Fr Anesth Reanim; 1996; 15(2):135-41. PubMed ID: 8734232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution, elimination, and action of vecuronium in the elderly.
    Lien CA; Matteo RS; Ornstein E; Schwartz AE; Diaz J
    Anesth Analg; 1991 Jul; 73(1):39-42. PubMed ID: 1677546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.
    Wright PM; Hart P; Lau M; Sharma ML; Gruenke L; Fisher DM
    Anesthesiology; 1994 Jul; 81(1):59-68; discussion 27A. PubMed ID: 7913801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetics of vecuronium in male and female patients.
    Xue FS; An G; Liao X; Zou Q; Luo LK
    Anesth Analg; 1998 Jun; 86(6):1322-7. PubMed ID: 9620528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis.
    Lebrault C; Duvaldestin P; Henzel D; Chauvin M; Guesnon P
    Br J Anaesth; 1986 Sep; 58(9):983-7. PubMed ID: 2875724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients.
    Sohn YJ; Bencini AF; Scaf AH; Kersten UW; Agoston S
    Anesth Analg; 1986 Mar; 65(3):233-9. PubMed ID: 2869721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular block by vecuronium: simulation with a flow-volume model.
    Nigrovic V
    Eur J Anaesthesiol; 1994 Mar; 11(2):65-74. PubMed ID: 7909750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative population pharmacokinetics of fentanyl using non-linear mixed effect modeling: burns vs. non-burns.
    Kaneda K; Han TH
    Burns; 2009 Sep; 35(6):790-7. PubMed ID: 19501972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of body fat on the onset of vecuronium induced neuromuscular blockade.
    Takaya T; Takeyama K; Miura M; Takiguchi M
    Tokai J Exp Clin Med; 2001 Oct; 26(3):107-11. PubMed ID: 11885752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium.
    Wright PM; McCarthy G; Szenohradszky J; Sharma ML; Caldwell JE
    Anesthesiology; 2004 Mar; 100(3):626-33. PubMed ID: 15108978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of the newer neuromuscular blocking drugs.
    Atherton DP; Hunter JM
    Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of vecuronium during acute isovolaemic haemodilution.
    Xue FS; Liao X; Tong SY; Liu JH; Li L; Zou Q; Luo LK
    Br J Anaesth; 1997 Nov; 79(5):612-6. PubMed ID: 9422901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent paralysis in critically ill patients after long-term administration of vecuronium.
    Segredo V; Caldwell JE; Matthay MA; Sharma ML; Gruenke LD; Miller RD
    N Engl J Med; 1992 Aug; 327(8):524-8. PubMed ID: 1353252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of acute moderate isovolumic hemodilution on the pharmacokinetics of vecuronium].
    Xue F; Liu Q; Zou Q; An G; Luo L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Dec; 19(6):456-60. PubMed ID: 10453539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of muscle relaxants in patients with burns.
    Martyn J; Goldhill DR; Goudsouzian NG
    J Clin Pharmacol; 1986; 26(8):680-5. PubMed ID: 2947935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.